New mutational signatures pinpoint causes of cancer and personalize treatment - The Science Board
4/27/2022 12:00:00 AM3 yearsago
by Joseph Constance, The Science Advisory Board contributing writer
by Joseph Constance, The Science Advisory Board contributing writer
Large-scale whole-genome sequencing of thousands of cancers has found previously unreported mutational signatures, including tumor-specific rare signatures, according to research published on April 21 in <em>Science.</em>
The findings are a significant addition to the current knowledgebase of cancer mutational signatures and could enhance personalized cancer treatments and diagnosis. They show how cancer genomic data … [+4761 chars]
full article...